Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CDI 988

Next Previous
Drug Profile

CDI 988

Alternative Names: CDI-988

Latest Information Update: 15 Apr 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Cocrystal Pharma Inc
  • Class Antivirals; Small molecules
  • Mechanism of Action 3C viral protease inhibitors; Coronavirus 3C protease inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Norovirus infections
  • Phase I COVID 2019 infections

Most Recent Events

  • 02 Apr 2026 CDI 988 receives Fast Track designation for Norovirus infections [PO] in USA
  • 01 Mar 2026 Phase-I/II clinical trials in Norovirus infections (Prevention) in USA (PO) (NCT07198139)
  • 31 Dec 2025 Cocrystal Pharma has patent pending applications for two families that are directed to the clinical candidate CDI 988 and structural brethren in the US and jurisdictions such as Australia, Brazil, Canada, China, Eurasia, EPO, Indonesia, Israel, India, Japan, Korea, Mexico, Malaysia, New Zealand, Philippines, Singapore, Thailand, Taiwan, and South Africa

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top